Constellation Brands, Inc. Profile Avatar - Palmy Investing

Constellation Brands, Inc.

Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Premier, Cor…
Beverages - Wineries & Distilleries
US, Victor [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q3 Q4 Δ in %
EV/EBITDA 27.39 78.48 61.61
Graham Fair Price -10.66 50.71 56.75
PEG -57.19 -1.29 -0.82
Price/Book 0.12 4.67 4.66
Price/Cash Flow 435.17 598.14 111.76
Prices/Earnings 33.63 28.96 21.67
Price/Sales 18.97 21.25 17.86
Price/FCF 435.17 598.14 111.76
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q3 Q4 Δ in %
Gross Profit Margin -7.92 0.47 0.51
Operating Margin -8.55 0.29 0.32
ROA -24.83 0.02 0.02
ROE 0.05 0.04 -25.08
ROIC 0.03 0.02 -20.78
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q3 Q4 Δ in %
Debt QOQ 0.07 < 0.005 10646.09
Dividends QOQ < 0.005 < 0.005 -973.87
EBIT QOQ -0.19 -0.21 -12.14
EPS QOQ -0.26 -0.22 14.99
FCF QOQ -0.39 -0.81 -104.99
Revenue QOQ -0.13 -0.13 -4.11
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q3 Q4 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 149.06 166.09 11.42
Days Sales Outstanding (DSO) 32.68 45.46 39.09
Inventory Turnover 0.60 0.54 -10.25
Debt/Capitalization 0.55 0.55 -0.28
Quick Ratio 0.29 0.39 35.90
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q3 Q4 Δ in %
Book Value 51.61 53.27 3.22
Cash 0.43 0.83 94.29
Capex -1.80 -1.95 -8.64
Free Cash Flow 2.15 0.42 -80.69
Revenue 13.46 11.69 -13.14
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q3 Q4 Δ in %
Current Ratio 1.05 1.19 12.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 12.84 16.83 31.04
Naive Interpretation Member
06 - Financial Health · Bad
End of STZ's Analysis
CIK: 16918 CUSIP: 21036P108 ISIN: US21036P1084 LEI: - UEI: -
Secondary Listings
STZ has no secondary listings inside our databases.